Project Objective: Development Candidate


Enhancing healing via Wnt-protein mediated activation of endogenous stem cells

All adult tissues contain stem cells. Some tissues, like bone marrow and skin, harbor more adult stem cells; other tissues, like muscle, have fewer. When a tissue or organ is injured these stem cells possess a remarkable ability to divide and multiply. In the end, the ability of a tissue to repair itself seems to […]

Autologous Retinal Pigmented Epithelial Cells Derived from Induced Pluripotent Stem Cells for the Treatment of Atrophic Age Related Macular Degeneration

The leading cause of visual loss in Americans over the age of 65 is age related macular degeneration (AMD) which occurs in both a “wet” and a “dry” form. Both forms of the disease are associated with loss of cells called retinal pigmented epithelium (RPE) which can lead to profound loss of central vision. Currently, […]

Development of a Stem Cell-based Transplantation Strategy for Treating Age-related Macular Degeneration

Age related macular degeneration (AMD) is a blinding disease of the elderly affecting nearly one in three individuals over the age of 75. Central vision is lost in AMD, severely impairing the ability to read, watch television, or drive. The epicenter of AMD is the retinal pigment epithelium (RPE), a single layer of cells in […]

Stem Cell-Based Therapy for Cartilage Regeneration and Osteoarthritis

Arthritis is the result of degeneration of cartilage (the tissue lining the joints) and leads to pain and limitation of function. Arthritis and other rheumatic diseases are among the most common of all health conditions and are the number one cause of disability in the United States. The annual economic impact of arthritis in the […]

Neural Stem Cells as a Developmental Candidate to Treat Alzheimer Disease

Alzheimer disease (AD), the most common cause of dementia among the elderly and the third leading cause of death, presently afflicts over 5 million people in the USA, including over 500,000 in California. Age is the major risk factor, with 5% of the population over age 65 affected, with the incidence doubling every 5 years […]

Sustained siRNA production from human MSC to treat Huntingtons Disease and other neurodegenerative disorders

One in every ten thousand people in the USA have Huntington’s Disease, and it impacts many more. Multiple generations within a family can inherit the disease, resulting in escalating health care costs and draining family resources. This highly devastating and fatal disease touches all races and socioeconomic levels, and there are currently no cures. Screening […]